Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-21-151723
Filing Date
2021-12-20
Accepted
2021-12-20 16:33:55
Documents
54
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2135789d1_10ka.htm 10-K/A 918835
2 EXHIBIT 31.1 tm2135789d1_ex31-1.htm EX-31.1 10933
3 EXHIBIT 31.2 tm2135789d1_ex31-2.htm EX-31.2 10876
4 EXHIBIT 32.1 tm2135789d1_ex32-1.htm EX-32.1 4748
5 EXHIBIT 32.2 tm2135789d1_ex32-2.htm EX-32.2 4775
  Complete submission text file 0001104659-21-151723.txt   4603860

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eucr-20201231.xml EX-101.INS 986537
7 XBRL TAXONOMY EXTENSION SCHEMA eucr-20201231.xsd EX-101.SCH 49809
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eucr-20201231_cal.xml EX-101.CAL 20382
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eucr-20201231_def.xml EX-101.DEF 142969
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eucr-20201231_lab.xml EX-101.LAB 333494
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eucr-20201231_pre.xml EX-101.PRE 261889
Mailing Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019
Business Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019 (212) 710-5220
Eucrates Biomedical Acquisition Corp. (Filer) CIK: 0001822929 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8
Type: 10-K/A | Act: 34 | File No.: 001-39650 | Film No.: 211505678
SIC: 6770 Blank Checks